BSEInsider Trading / SAST7 Oct 2026 · 7 Oct 2026, 10:38 am

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Archana Lonkar

iSERA Lifesciences Ltd · 534920

✦ AI SummaryPledge

iSERA Lifesciences Ltd's promoter, Archana Kakasaheb Lonkar, has submitted a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding a change in her shareholding in the company due to the allotment of equity shares under a preferential allotment (share swap) by the board of directors on October 01, 2026.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

iSERA Lifesciences Ltd - 534920 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Attachments (1)

📄

79C01AAA_264C_4166_92D4_78E2664C4B52_103800.pdf

pdf

Download →
View document text
October 05, 2026 To, To, The Manager, The Board of Directors, Listing Operations Department iSERA Lifesciences Limited BSE Limited 301, Samath Aishwarya, Opp. Medipoint P.J. Towers, Dalal Street, Hospital, Off New DP Road, Aundh, Mumbai -400 001 Pune– 4110 07, Maharashtra Sub: Disclosure pursuant to Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. SCRIP CODE: 534920 ISIN: INE899M0 1020 Dear SirMadam, This is to inform that I, Archana Kakasaheb Lonkar, Promoter of iSERA Lifesciences Limited ("Target Company") resident of 1301 Apollonia, Triveni Laurel, Near Birla School, Kalyan (W), Beside R.T.O Kalyan-421301, hereby submit the disclosure with regard to the change in my shareholding in the Target Company arising pursuant to the allotment of Equity Shares to me under Preferential Allotment (Share Swap) by the Board of Directors of the Target Company at its meeting held on October 01, 2026. With reference to the aforementioned subject, please find enclosed herewith the disclosure as per Regulation 29(2)o f SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This is for your information and record. Yours truly, Archana Kakasaheb Lonkar Promoter Format for disclosures under Regulation 2\2) of SE.BI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Name of the Target (ompany(T) iSERA Lifesciences Limited ("TC") Office No. Al-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pune - 411001 Name(s) of the acquirer and Persons Archana Kakasaheb Lonkar Concert (PAC) with the PAN: AVLPK8551G Acting acquirer Whether the acquirer belongs to Yes, the Acquirer is a Promoter of the TC Promoter/P romoter group Name(s)of the StockExchange(s) where the BSE Limited (Scrip Code: 534920) shares of TC are Listed Details of the acquisition / disposal as follows Number % %w.r.t. total W.r.t.totalshare diluted ivoting capital share/voting capitalof the wherever applicable(*) TC(**) Before the acquisition under consideration, bolding of: a) Shares carrying voting rights 7,00,000 8.32% 8.32% b} Shares in the nature ef eneumbranee (pledge iea non dispesal undertaking ethers) e) Votig rights fVR} otherwise than by sheres d) Werrentseenvertibleseeurties/any ether instrament that entittes-the sequirer te Feeeve-sheres-earryng vetng ights in-the Tetspeeify helding in-eaeh eategery) e) Total (atbtctd) 7,00,000 8.32% 8.32% Details of acquisition/sale a) Shares carrying voting rights acquired 4,95,000 2.01% 2.01% seld b) VRs aequired tseld otherwise-than by sheres e) Warants/eenvertibleseeuritiestanyother instrment thet entittes-the- eequtrerte Feeeive shereS earrying voting ights-in the Te fspeeify holding-i-eaeh-eategery) aequiredseld d) Sheres enetmbered finvekedtreleased by the-aeeirer 4,95,000 2.01% 2.01% e) Total(atbtct/-d) After the acquisition /sale, holding of: a) Shares canying voting rights acquired 11,95,000 4.86% 4.86% b) Sheres eneHmbered witlh- the aeqrer ) VRsetherwisethanbyshares d Warants eeRVertibłe seeurities any ether instrument that entitles the-aeqirer te-receive shares-earrying vəting rights-in the Te topeeify hełding in eaeh eategory) afteraequisitiOR e) Total(atbtc+d) 11,95,000 4.86% 4.86% Mode of acquisition/sale (e.g. open market/off- Preferential Allotment (Share Swap) pursuant to marketpublic issuc/rights issue / preferential the allotment of Equity Shares by the Board of allotment /inter-se transfer ctc). Directors of the Target Company at its meeting held on October 01, 2026 Date of acquisition/saleefsheres/VR or date of October 01, 2026 receipt of intimation of allotment of shares, whichever is applicable Equity share capitaltotal voting capital of the Equity Capital Rs. 8,40,89,720/ TCb efore the said acquisition /sałe 84,08,972 Equity Shares of Rs. 10/-cach Equity share capital/total voting capital Equity Capital Rs. 24,59, 17,720/ of the TC after the said acquisition/sałe 2,45,91,772 Equity Shares of Rs. 100-cach Equity Capital Rs. 24,59,17,720/ Total diluted share/voting capital of the TC after the said acquisition 2,45,91,772 Equity Shares of Rs. l0/-cach () Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement. (**) Diluted share/ voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. Archana Kakasaheb Lonkar Promoter Date: October 05, 2026 *****